As of 2026-03-31, the Relative Valuation of Turning Point Therapeutics Inc (TPTX) is (166.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 76.01 USD, the upside of Turning Point Therapeutics Inc based on Relative Valuation is -319.7%.
The range of the Relative Valuation is (150.39) - (179.47) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.8x - 26.0x | 23.8x |
| Forward P/E multiples | 21.3x - 29.0x | 24.7x |
| Fair Price | (150.39) - (179.47) | (166.96) |
| Upside | -297.9% - -336.1% | -319.7% |
| Date | P/E |